Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Possible Side Effects and Precautions Common side effects include: Nausea or vomiting (especially in early weeks) Bloating or mild stomach discomfort Fatigue Rare: pancreatitis or gallbladder issues Important: Never start GLP-1 therapy without consulting a doctor
Bruises typically clear in 3-5 days
Component-Level Trial Findings CJC-1295 (without DAC, modified GRF 1-29) Phase 1 and Phase 2 work described: Dose-dependent GH elevation (2-10x baseline at studied doses, PMID 16352683) IGF-1 elevation of 1.5-3x baseline at 1-2 weeks Mild facial flushing post-injection in some participants No serious adverse events at studied doses CJC-1295 with DAC The DAC-modified version covalently binds to albumin, extending half-life to 5-8 days (PMID 16352683)
When asked if patients had noticed that attitudes towards them had changed when they had lost weight, 54% or patients surveyed agreed that attitudes towards them had changed, with 49% of those describing reduced weight related stigma, bias or discrimination
